These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 38226182)

  • 1. Association Between Germline
    Luo Y; Pan R; Rao H; Chen X; Yang H
    Int J Gen Med; 2024; 17():75-84. PubMed ID: 38226182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological characteristics and BRCA1/BRCA2 pathogenic variants of patients with breast cancer.
    Eras N; Tuncel F; Altıntas Z; Erden S
    Pol J Pathol; 2024; 75(1):1-7. PubMed ID: 38741424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent RB1 loss and
    Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang EY; Nelson GS; Ghatage P; Lee CH; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Blake Gilks C; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; ; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Singh N; Rinda Soong T; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW
    medRxiv; 2023 Nov; ():. PubMed ID: 37986741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into BRCA Cancer Predisposition from Integrated Germline and Somatic Analyses in 7632 Cancers.
    Yost S; Ruark E; Alexandrov LB; Rahman N
    JNCI Cancer Spectr; 2019 Jun; 3(2):pkz028. PubMed ID: 31360904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic variants of potential clinical significance in the tumors of
    Buckingham L; Mitchell R; Maienschein-Cline M; Green S; Hu VH; Cobleigh M; Rotmensch J; Burgess K; Usha L
    Hered Cancer Clin Pract; 2019; 17():21. PubMed ID: 31346352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1/2 Variants and Metabolic Factors: Results From a Cohort of Italian Female Carriers.
    Oliverio A; Bruno E; Colombo M; Paradiso A; Tommasi S; Daniele A; Terribile DA; Magno S; Guarino D; Manoukian S; Peissel B; Radice P; Pasanisi P
    Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33266155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The BRCA mutation spectrum among breast and ovarian cancers in India: highlighting the need to screen BRCA1 185delAG among South Indians.
    John AO; Singh A; Yadav P; Joel A; Thumaty DB; Fibi Ninan K; Georgy JT; Cherian AJ; Thomas S; Thomas A; Thomas V; Peedicayil A; Varghese D; Parthiban R; Ravichandran L; Johnson J; Thomas N; Yadav B; Patricia S; Selvamani B; Abraham D; Paul MJ; Chacko RT; Chapla A
    Eur J Hum Genet; 2024 Mar; ():. PubMed ID: 38538877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary Breast and Ovarian Cancer in Families from Southern Italy (Sicily)-Prevalence and Geographic Distribution of Pathogenic Variants in
    Incorvaia L; Fanale D; Badalamenti G; Bono M; Calò V; Cancelliere D; Castiglia M; Fiorino A; Pivetti A; Barraco N; Cutaia S; Russo A; Bazan V
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32380732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased TP53 somatic evolution in peritoneal washes of individuals with BRCA1 germline mutations.
    Tee XR; Hazard E; Latorre-Esteves E; Kohrn BF; Ghezelayagh TS; Fredrickson JU; Coombes C; Radke MR; Manhardt E; Katz R; Soong TR; Swisher EM; Norquist BM; Risques RA
    Gynecol Oncol; 2024 Aug; 190():18-27. PubMed ID: 39128337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of potentially actionable genetic variants in epithelial ovarian cancer: a retrospective cohort study.
    Fieuws C; Van der Meulen J; Proesmans K; De Jaeghere EA; Loontiens S; Van Dorpe J; Tummers P; Denys H; Van de Vijver K; Claes KBM
    NPJ Precis Oncol; 2024 Mar; 8(1):71. PubMed ID: 38519644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fertility and Pregnancy-Related Issues in Young
    Magaton IM; Arecco L; Mariamidze E; Jankovic K; Stana M; Buzzatti G; Trevisan L; Scavone G; Ottonello S; Fregatti P; Massarotti C; von Wolff M; Lambertini M
    Breast Cancer (Auckl); 2024; 18():11782234241261429. PubMed ID: 38882447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A de novo germline pathogenic BRCA1 variant identified following an osteosarcoma pangenomic molecular analysis.
    Mouren A; Chansavang A; Hamzaoui N; Srikaran A; Laurent-Puig P; Marisa L; De Percin S; Lupo A; Larousserie F; Blons H; L'Haridon A; Burnichon N; Pasmant E; Tlemsani C
    Fam Cancer; 2024 May; ():. PubMed ID: 38763984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathological Features of Non-Neoplastic Breast Parenchyma Do Not Predict BRCA Mutation Status of Patients with Invasive Breast Cancer.
    Bayraktar S; Qiu H; Liu D; Shen Y; Gutierrez-Barrera AM; Arun BK; Sahin AA
    Biomark Cancer; 2015; 7():39-49. PubMed ID: 26327783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exome sequencing identifies
    Dicks EM; Tyrer JP; Ezquina S; Jones M; Baierl J; Peng PC; Diaz M; Goode E; Winham SJ; Dörk T; Van Gorp T; De Fazio A; Bowtell D; Odunsi K; Moysich K; Pavanello M; Campbell I; Brenton JD; Ramus SJ; Gayther SA; Pharoah PDP
    medRxiv; 2024 Apr; ():. PubMed ID: 38633804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic epidemiology of BRCA1- and BRCA2-associated cancer across Latin America.
    Herzog JS; Chavarri-Guerra Y; Castillo D; Abugattas J; Villarreal-Garza C; Sand S; Clague-Dehart J; Alvarez-Gómez RM; Wegman-Ostrosky T; Mohar A; Mora P; Del Toro-Valero A; Daneri-Navarro A; Rodriguez Y; Cruz-Correa M; Ashton-Prolla P; Alemar B; Mejia R; Gallardo L; Shaw R; Yang K; Cervantes A; Tsang K; Nehoray B; Barrera Saldana H; Neuhausen S; Weitzel JN
    NPJ Breast Cancer; 2021 Aug; 7(1):107. PubMed ID: 34413315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical consensus recommendation on when to do BRCA testing.
    Parikh PM; Wadhwa J; Minhas S; Gupta A; Mittal S; Ranjan S; Mehta P; Singh R; Kataria SP; Salim S; Ahmed M; Aggarwal S
    South Asian J Cancer; 2018; 7(2):106-109. PubMed ID: 29721474
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinicopathological analysis of early-stage breast cancer patients that meet indications for
    Xiang H; Xin L; Liu Q; Zhang H; Zhang S; Ye J; Cheng Y; Li T; Liu Y; Xu L
    Chin J Cancer Res; 2020 Apr; 32(2):163-174. PubMed ID: 32410794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of the functional impact of missense variants in BRCA1 and BRCA2 with BRCA-ML.
    Hart SN; Polley EC; Shimelis H; Yadav S; Couch FJ
    NPJ Breast Cancer; 2020; 6():13. PubMed ID: 32377563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged response of relapsed high grade serous ovarian carcinoma to the oral angiokinase inhibitor nintedanib in a patient with a germline BRCA1 mutation.
    Wong HH; Parkinson C; Ledermann JA; Brenton JD; Merger M; Shaw A; Patterson A; Shafi M; Earl HM
    Gynecol Oncol Case Rep; 2012; 3():7-10. PubMed ID: 24371652
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.